BNTC · NASDAQ
Benitec Biopharma (BNTC) Stock Price & Fundamentals
Benitec Biopharma (BNTC) closed at $286.14 on Oct 9, 2026, up 0.10% from the previous close of $285.84.
Share price, past year
1Y +35.76%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $286.14 |
| Sep 30, 2026 | $288.98 |
| Aug 31, 2026 | $294.13 |
| Jul 31, 2026 | $280.92 |
| Jun 30, 2026 | $293.47 |
| May 29, 2026 | $285.91 |
| Apr 30, 2026 | $291.55 |
| Mar 31, 2026 | $286.23 |
| Feb 27, 2026 | $271.28 |
| Jan 30, 2026 | $257.92 |
| Dec 31, 2025 | $241.85 |
| Nov 28, 2025 | $229.36 |
| Oct 31, 2025 | $205.34 |
Key statistics
- Market cap
- $9.85B
- P/E (TTM)
- —
- EPS (TTM)
- −$0.98
- Revenue (TTM)
- —
- Net income (TTM)
- −$45.55M
- Shares outstanding
- 34.4M
- Dividend yield
- —
- 52-week range
- $203.65 – $295.95
Benitec Biopharma's market cap is $9.85B, based on a share price of $286.14 and 34.4M shares outstanding as of Jun 30, 2026.
Financials
Benitec Biopharma reported revenue of $0.00 for fiscal 2024, down 100.00% from fiscal 2023.
Benitec Biopharma reported a net loss of $45.55M in fiscal 2026.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Jun 30, 2024 | $0.00 | −100.0% | −$21.75M | — | −$1.22 | −$19.58M |
| FY2023ended Jun 30, 2023 | $75.00K | +2.7% | −$19.56M | −26,082.7% | −$14.12 | −$18.01M |
| FY2022ended Jun 30, 2022 | $73.00K | +23.7% | −$18.21M | −24,942.5% | −$37.88 | −$15.91M |
| FY2021ended Jun 30, 2021 | $59.00K | −42.2% | −$13.88M | −23,528.8% | −$3.23 | −$13.05M |
| FY2020ended Jun 30, 2020 | $102.00K | −99.2% | −$8.27M | −8,111.8% | −$8.10 | −$7.63M |
| FY2019ended Jun 30, 2019 | $12.20M | — | $2.61M | 21.4% | $3.05 | $4.39M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2026ended Mar 31, 2026 | $0.00 | −$11.94M | −$0.24 |
| Q2 FY2026ended Dec 31, 2025 | $0.00 | −$11.84M | −$0.26 |
| Q1 FY2026ended Sep 30, 2025 | $0.00 | −$8.97M | −$0.22 |
| Q3 FY2025ended Mar 31, 2025 | $0.00 | −$14.50M | −$0.38 |
| Q2 FY2025ended Dec 31, 2024 | $0.00 | −$9.55M | −$0.26 |
| Q1 FY2025ended Sep 30, 2024 | $0.00 | −$5.06M | −$0.18 |
| Q4 FY2024ended Jun 30, 2024 | $0.00 | — | — |
| Q3 FY2024ended Mar 31, 2024 | $0.00 | — | — |
Company profile
- Name
- Benitec Biopharma Inc.
- Ticker
- BNTC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 3940 Trust Way, Hayward, CA 94545
- Incorporated in
- DE
- Fiscal year ends
- June
- SEC CIK
- 0001808898
Recent SEC filings
- Oct 5, 2026
- Sep 30, 2026
- Sep 24, 2026
- Sep 14, 2026
- Sep 14, 2026
- May 29, 2026
- May 14, 2026
- May 14, 2026
Frequently asked questions
What is Benitec Biopharma's stock price?
Benitec Biopharma (BNTC) closed at $286.14 on Oct 9, 2026, up 0.10% from the previous close of $285.84.
What is Benitec Biopharma's market cap?
Benitec Biopharma's market cap is $9.85B, based on a share price of $286.14 and 34.4M shares outstanding as of Jun 30, 2026.
How much revenue does Benitec Biopharma make?
Benitec Biopharma reported revenue of $0.00 for fiscal 2024, down 100.00% from fiscal 2023.
Does Benitec Biopharma pay a dividend?
Benitec Biopharma's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Benitec Biopharma Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures